Professional Documents
Culture Documents
Colorectum
2 171 (14.2%)
Lung
1 707 (11.2%)
Liver
852 (5.6%)
Prostate
833 (5.5%)
Total: 15 284
4 041 068
Other cancers
3 560 (44.6%) Colorectum Number of new cases
1 241 (15.6%)
Prostate
833 (10.4%) 15 284
Number of deaths
Stomach Liver
8 508
483 (6.1%) 539 (6.8%)
Total: 7 979
Breast
1 646 (22.5%) 32 220
Other cancers Data source and methods
3 227 (44.2%)
Colorectum
930 (12.7%) Incidence
Cervix uteri Country-specific data source: No data
639 (8.7%) Method: Estimated from national mortality estimates by
modelling, using mortality:incidence ratios derived from
cancer registry data in neighbouring countries
Lung Corpus uteri
384 (5.3%) 479 (6.6%)
Mortality
Total: 7 305
Country-specific data source: National (WHO)
Method: National rates projected to 2018
Summary statistic 2018
Prevalence
Males Females Both sexes Computed using sex-; site- and age-specific incidence to
Population 1 937 429 2 103 639 4 041 068 1-;3- and 5-year prevalence ratios from Nordic countries for
the period (2000-2009), and scaled using Human
Number of new cancer cases 7 979 7 305 15 284
Development Index (HDI) ratios.
Age-standardized incidence rate (World) 310.5 216.6 254.3
Risk of developing cancer before the age of 75 years (%) 46.2 32.6 38.1
Number of cancer deaths 4 973 3 535 8 508
Age-standardized mortality rate (World) 191.8 97.7 137.1
Risk of dying from cancer before the age of 75 years (%) 34.3 19.7 25.7
5-year prevalent cases 14 589 17 631 32 220
Top 5 most frequent cancers excluding non-melanoma skin cancer Lung Breast Colorectum
(ranked by cases) Colorectum Colorectum Lung
Prostate Cervix uteri Breast
Liver Corpus uteri Liver
Stomach Lung Prostate
The Global Cancer Observatory - All Rights Reserved - January, 2019. Page 1
Republic of Moldova
Source: Globocan 2018
Males Females
Breast 48.2
Prostate 32.1
60 40 20 0 20 40 60
ASR (World) per 100 000
Incidence Mortality
60 50 40 30 20 10 0 10 20 30 40 50 60
ASR (World) per 100 000
The Global Cancer Observatory - All Rights Reserved - January, 2019. Page 2